Schmid Timothy

EVP, WW Chair, MedTech · SEC CIK 1998491
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$5.92M
4 trades
Net flow
−$5.92M
Net selling
Total filings
26
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
JNJ
Sell Schmid Timothy · EVP, WW Chair, MedTech · Open-market sale · filed Feb 23, 2026 ΔOwn −4.9%

Schmid Timothy sold $324.8K of JNJ, trimming their stake 5%.

−$324.8K
1,322 sh @ $246
JNJ
Option exercise Schmid Timothy · EVP, WW Chair, MedTech · Option exercise · filed Feb 18, 2026 ΔOwn +51%
+$1.58M
13,625 sh @ $116
JNJ
Sell Schmid Timothy · EVP, WW Chair, MedTech · Open-market sale · filed Feb 18, 2026 ΔOwn −34%

Schmid Timothy sold $3.33M of JNJ, trimming their stake 34%.

−$3.33M
13,625 sh @ $244
JNJ
Option exercise Schmid Timothy · EVP, WW Chair, MedTech · Option exercise · filed Feb 18, 2026 ΔOwn +34%
+$1.17M
8,998 sh @ $130
JNJ
Sell Schmid Timothy · EVP, WW Chair, MedTech · Open-market sale · filed Feb 18, 2026 ΔOwn −25%

Schmid Timothy sold $2.2M of JNJ, trimming their stake 25%.

−$2.2M
8,998 sh @ $245
Advertisement
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 18, 2026 ΔOwn −0.1%
−$3.7K
15 sh @ $243
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 18, 2026 ΔOwn −1.6%
−$109.1K
448 sh @ $243
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 18, 2026 ΔOwn −6.7%
−$444.1K
1,816 sh @ $245
JNJ
Option exercise Schmid Timothy · EVP, WW Chair, MedTech · Option exercise · filed Feb 10, 2026 ΔOwn +92%
+$1.59M
15,571 sh @ $102
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 10, 2026 ΔOwn −32%
−$2.48M
10,335 sh @ $240
JNJ
Sell Schmid Timothy · EVP, WW Chair, MedTech · Open-market sale · filed Feb 18, 2025 ΔOwn −2.6%

Schmid Timothy sold $62.9K of JNJ, trimming their stake 3%.

−$62.9K
403 sh @ $156
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 18, 2025 ΔOwn −5.7%
−$159.1K
1,015 sh @ $157
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 18, 2025 ΔOwn −1.4%
−$30K
193 sh @ $155
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 18, 2025 ΔOwn −4.2%
−$100.1K
639 sh @ $157
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 15, 2024 ΔOwn −1.9%
−$39.5K
250 sh @ $158
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 14, 2024 ΔOwn −18%
−$454.4K
2,887 sh @ $157
JNJ
Tax withholding Schmid Timothy · EVP, WW Chair, MedTech · Tax withholding · filed Feb 12, 2024 ΔOwn −9.1%
−$156.5K
1,001 sh @ $156

Frequently asked questions

How is Schmid Timothy's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Schmid Timothy's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.